What is Bioplate?
Based in California, Bioplate operates as a specialized manufacturer of high-precision neurosurgical products. For over two decades, the firm has refined its portfolio to include advanced titanium plates, sterile surgical kits, and innovative bioresorbable materials. By prioritizing cost-effective manufacturing and rapid supply chain logistics, Bioplate addresses the critical needs of neurosurgeons and maxillofacial specialists. Their market position is defined by a dual commitment to clinical efficacy and operational efficiency, ensuring that healthcare providers receive reliable, high-quality surgical hardware on demand.
How much funding has Bioplate raised?
Bioplate has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Bioplate
PPP
Public-Private Partnership
What's next for Bioplate?
With the infusion of this latest capital, Bioplate is expected to accelerate its research and development initiatives, particularly in the realm of bioresorbable materials which represent the next frontier in cranial reconstruction. The strategic focus will likely shift toward scaling production capabilities to meet the growing global demand for minimally invasive surgical tools. Furthermore, the company is poised to enhance its inventory management infrastructure, ensuring that its distribution network remains robust against supply chain volatility. As the firm transitions through this late-stage growth phase, the emphasis will remain on maintaining its reputation for quality while exploring new geographic markets for its specialized surgical portfolio.
See full Bioplate company page
